Immuneering (IMRX) Goodwill & Intangibles (2021 - 2026)
Immuneering (IMRX) posted quarterly Goodwill & Intangibles of $7.0 million for Q1 2026, little changed year-over-year from $7.0 million in Q1 2025, and little changed quarter-over-quarter from $7.0 million in Q4 2025.
Analysis
Immuneering (IMRX) Goodwill & Intangibles (2021 - 2026) Analysis & Trends
Immuneering's Goodwill & Intangibles history runs 6 years deep, the most recent figure standing at $7.0 million for Q1 2026.
- In Q1 2026, Goodwill & Intangibles changed 0.42% year-over-year to $7.0 million; the TTM figure through Mar 2026 stood at $7.0 million (changed 0.42% YoY), while the FY2025 annual figure was $7.0 million, changed 0.42% from the prior year.
- Goodwill & Intangibles for Q1 2026 stood at $7.0 million, roughly flat from $7.0 million in the prior quarter.
- The five-year high for Goodwill & Intangibles was $7.1 million in Q1 2022, with the low at $7.0 million in Q1 2026.
- The 5-year median for Goodwill & Intangibles is $7.1 million (2024), against an average of $7.1 million.
- The sharpest annual moves came in 2022 and 2023: Goodwill & Intangibles slipped 0.58% in 2022, then fell 0.41% in 2023.
- Immuneering's Goodwill & Intangibles stood at $7.1 million in 2022, then fell by 0.41% to $7.1 million in 2023, then dropped by 0.41% to $7.0 million in 2024, then dropped by 0.42% to $7.0 million in 2025, then declined by 0.1% to $7.0 million in 2026.
- Business Quant data shows IMRX's Goodwill & Intangibles at $7.0 million in Q1 2026, $7.0 million in Q4 2025, and $7.0 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn |
| 10 | Immuneering | 316.05 Mn | 316.05 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.00 Mn |
| Mar 31, 2026 | 7.00 Mn |
| Dec 31, 2025 | 7.01 Mn |
| Sep 30, 2025 | 7.02 Mn |
| Jun 30, 2025 | 7.03 Mn |
| Mar 31, 2025 | 7.03 Mn |
| Dec 31, 2024 | 7.04 Mn |
| Sep 30, 2024 | 7.05 Mn |
| Jun 30, 2024 | 7.06 Mn |
| Mar 31, 2024 | 7.06 Mn |
| Dec 31, 2023 | 7.07 Mn |
| Sep 30, 2023 | 7.08 Mn |
| Jun 30, 2023 | 7.08 Mn |
| Mar 31, 2023 | 7.09 Mn |
| Dec 31, 2022 | 7.10 Mn |
| Sep 30, 2022 | 7.11 Mn |
| Jun 30, 2022 | 7.11 Mn |
| Mar 31, 2022 | 7.12 Mn |
| Dec 31, 2021 | 7.14 Mn |